Kore Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kore Private Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,208	Closed	-$314K	–	315
2021 Q3	$314K	Hold	4,208	–	–	0.03%	320
2021 Q2	$389K	Sell	4,208 -200	-5%	-$17K	0.04%	262
2021 Q1	$391K	Buy	4,408 +1,974	+81%	+$196K	0.05%	221
2020 Q4	$227K	Buy	+2,434	New	+$194K	0.04%	293

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Kore Private Wealth's ARKG Position: Q4 2021 in Review

Kore Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 4,208 shares — an estimated $314K sold.

Kore Private Wealth first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $391K in Q1 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

Kore Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
Kore Private Wealth sold 4,208 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $314K.
Kore Private Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
Kore Private Wealth's ARK Genomic Revolution ETF position peaked at $391K in Q1 2021.
460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Kore Private Wealth's 13F filing for Q4 2021, filed 11 Feb 2022.